New patent expiration for Celgene drug ISTODAX

This drug has 5 patent member of the family in five nations.

For more details on how DrugPatentWatch can assist with your pharmaceutical company intelligence requires, contact [email protected] or go to www.DrugPatentWatch.com

Drug patent lawsuits for ISTODAX.

The generic ingredient in ISTODAX is romidepsin. 2 providers are listed for this substance. Additional information are available on the romidepsin profile page.

Istodax is a drug marketed by Celgene and is included in one NDA. It is readily available from 2 providers. There are two patents securing this drug and one Paragraph IV obstacle.

Copyright ©
DrugPatentWatch. Originally published at
New patent expiration for Celgene drug ISTODAXAnnual Drug Patent Expirations for ISTODAX

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright ©
DrugPatentWatch. Originally published at
New patent expiration for Celgene drug ISTODAX

Share this:

The generic component in ISTODAX is romidepsin.

LinkedIn
Twitter
Facebook
Email

Istodax is a drug marketed by Celgene and is included in one NDA. It is readily available from two providers. There are two patents safeguarding this drug and one Paragraph IV difficulty.

Related

Leave a Reply

Your email address will not be published. Required fields are marked *